Posts category

Uncategorized

#22: Point-of-Care Messaging and Boosted Vaccine Uptake

/

February 28, 2025

#26: Moderna Faces Manufacturing Costs and Revenue Challenges

/

February 25, 2025

#25: Romvimza Receives FDA Approval for TGCT Treatment

/

February 21, 2025

#25: Romvimza Receives FDA Approval for TGCT Treatment

/

February 21, 2025

#24: US Pharma And Life Sciences Deals: 2025

/

January 24, 2023

#23: Big Pharma’s China Sourcing, New Strategies

/

January 23, 2023

#21: Pfizer’s New Obesity Drug.

/

January 21, 2023

#20: Acquiring Patient Social Networks To Boost Marketing

/

January 20, 2023

#19: RSV Vaccine Labels to Include New Warning

/

January 19, 2023

#18: The Future of Pharma Marketing

/

January 18, 2023